| CODX Snapshot | |
|---|---|
| Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah. | |
| VALUATION DATA | |
| Market Capitalization | $38,449,400 | Price to Sales | 1.00 |
| Earnings per Share | $-1.2000 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $1.2200 |
| 52 Week High | $5.51 |
| 52 Week Low | $0.429 |
| 50-Day Moving Average | $0.184 |
| 200-Day Moving Average | $0.45 |
| All data are from Alpha Vantage as of today. For more infomation on CODX see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search